Just as we did, the Food and Drug Administration has recognized the growing enthusiasm for exploring opportunities to use psychedelic medications to treat mental health disorders. In June, FDA issued for the first time draft guidance providing considerations for those developing psychedelic drugs for the treatment of medical conditions. The guidance explicitly focuses on “classic
My goodness. It happened again.
I have literally (yes, literally) lost track of the number of times that the Alabama Medical Cannabis Commission or a court has ordered a halt to the AMCC’s efforts to issue licenses to medical cannabis operators. If you listened to the commission and its counsel today as it announced the
According to a report from Bloomberg News, the U.S. Department of Health and Human Services (HHS) is officially recommending to the U.S. Drug Enforcement Agency (DEA) that marijuana be moved from Schedule I to Schedule III under federal law. The move follows a directive issued by President Biden last year that Secretary of Health
There is a scene in the fantastic film Wayne’s World (cult classic or blockbuster, I don’t know; I just write blogs about cannabis) where Wayne and Garth are playing street hockey and whenever a car drives down the street they both yell “Game off!” and move the goal off the road. Once the car has
A question frequently encountered in the cannabis industry involves a cannabis user’s gun rights. This stems from the ever-present federal and state law tension overlaying marijuana in the United States — thanks to the Schedule 1 status of “marihuana” under the Controlled Substances Act. A Westlaw search quickly reveals that over the past year federal
Last Thursday was License Award Day 2.0 for the Alabama Medical Cannabis Commission. The more things change, the more they stay the same. Nineteen of the applicants awarded licenses in June, before the process was halted due to then-unexplained “inconsistencies” in the scoring process, were awarded licenses the second time around. That came as no
In a court hearing yesterday in the Montgomery County Circuit Court, it appeared that the staff of the Alabama Medical Cannabis Commission was prepared to move forward announcing licensees at its meeting on Thursday and that Judge James Anderson – entrusted with all current medical cannabis litigation – would allow for that process to play
Pursuant to the Mississippi Medical Cannabis Act, Mississippi residents can petition the state’s Department of Health to add new serious medical conditions or their treatments to the existing list of conditions that qualify a prospective patient for a medical marijuana card (Miss. Code Ann. § 41-137-17). Exercising this authority, the DOH recently made it easier
Word began circulating a few days ago that tobacco giant Philip Morris has agreed to purchase Israeli cannabis company Syqe Medical for a whopping $650 million if certain future events come to fruition. While the two companies evidently have some history together, this new deal is reportedly tied to Philip Morris’ interest in acquiring Syqe’s
We’ve been tossing this idea around in our heads ever since research about microdosing psychedelics entered the mainstream media a few years ago. And the more we think about it, the more we think Congress may allow patient access to psychedelic treatments before it does so for marijuana.
Before you think we’ve been consuming too